Skip to main content
. 2022 Feb 15;37(4):687–699. doi: 10.1002/jbmr.4503

Fig. 8.

Fig. 8

Increased bone formation in anti‐sclerostin antibody‐treated mice as evaluated by bone histomorphometric analysis. Evaluation of (A) bone area and (B) trabecular thickness in mice treated with the anti‐sclerostin antibody versus vehicle‐treated mice.